Press Releases Swedish Orphan Biovitrum AB

Equities

SOBI

SE0000872095

Market Closed - Nasdaq Stockholm Other stock markets 11:29:55 2024-06-07 am EDT			5-day change	1st Jan Change
281 ^SEK	-2.63%		-0.50%	+5.24%

May. 28	BerGenBio ASA Enter into A Clinical Trial Agreement with the Mays Cancer Center At the University of Texas Health Science Center At San Antonio and Swedish Orphan Biovitrum AB	CI
May. 24	Sobi North America Gets FDA Fast Track Designation for Rheumatic Disease Complication Treatment	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sobi to present new myelofibrosis data at the ASCO 2024 Annual Meeting	May. 24	GL
Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome	May. 24	GL
Bulletin from Sobi's Annual General Meeting (AGM)	May. 14	AQ
Sobi has completed SEK 3 billion senior bond issue	May. 08	AQ
Aspaveli® (pegcetacoplan) approved in Europe for use among treatment naïve adult patients with PNH	May. 08	AQ
Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A	Apr. 26	AQ
Sobi establishes MTN programme with a framework amount of SEK 10 billion, publishes a base prospectus	Apr. 26	AQ
Swedish Orphan Biovitrum : 25 april - Q1 2024 rapport	Apr. 25	PU
Swedish Orphan Biovitrum : 25 April - Q1 2024 report	Apr. 25	PU
Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio	Apr. 25	AQ
Invitation: Sobi's Q1 2024 report	Apr. 15	PU
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)	Apr. 04	AQ
Swedish Orphan Biovitrum : Sobi publishes Annual and sustainability report for 2023	Apr. 02	PU
Sobi publishes Annual and sustainability report for 2023	Apr. 02	AQ
Swedish Orphan Biovitrum : Sobi announces positive results from phase 3 study of Doptelet® for treatment of children and adolescents with ITP	Mar. 25	PU
Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024	Feb. 08	AQ
Sobi to present new data at EAHAD 2024	Jan. 31	AQ
Sobi's Chairman of the Board resigns due to health reasons	Jan. 05	AQ
Change in number of shares and votes in Swedish Orphan Biovitrum AB (publ)	Nov. 30	AQ
Sobi to present new data at ASH 2023 Annual Meeting	Nov. 20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Swedish Orphan Biovitrum AB

Equities

SOBI

SE0000872095

Press Releases

Filters